The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction
- PMID: 32557399
- DOI: 10.1007/s13187-020-01793-3
The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction
Abstract
Cancer patients and survivors frequently experience cognitive deficits, including problems with attention and memory. These symptoms, referred to as cancer-related cognitive dysfunction (CRCD), are associated with distress. Learning about CRCD and self-management strategies may improve functioning and quality of life in cancer survivors. This study describes the development and evaluation of a CRCD resource for cancer patients. An educational booklet was developed in accordance with multiple evidence-based guidelines for cancer patient education. Cancer patients on chemotherapy (N = 113; 34% men; median age 55, range 19-85) reviewed the booklet and self-reported CRCD knowledge before and after reading the booklet. They also gave ratings on general impressions of the booklet. Seventy-five percent of participants reported that the resource increased their self-reported CRCD knowledge. A Wilcoxon signed-rank test demonstrated that exposure to the booklet elicited a statistically significant change in self-reported knowledge (Z = - 7.13, p < 0.001). A repeated-measures ANCOVA determined that the means of self-reported CRCD knowledge were significantly different between pre- and post-exposure (F(1, 92) = 7.96, p = 0.006, η2 = 0.08). Exploratory analyses revealed that self-reported CRCD knowledge increased across all educational attainment levels from pre- to post-exposure. Ninety-one percent of participants reported that all patients undergoing cancer treatment would find this booklet helpful. Cancer patients at risk for cognitive challenges gained self-reported CRCD knowledge from the booklet, and they think this knowledge would be helpful to others. A resource that makes CRCD understandable and manageable can bridge the gap in self-rated knowledge across education levels.
Keywords: Cancer survivorship; Cancer-related brain fog; Cancer-related cognitive impairment; Chemobrain; Patient education; Symptom management.
© 2020. American Association for Cancer Education.
Similar articles
-
A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study.Support Care Cancer. 2018 Aug;26(8):2851-2859. doi: 10.1007/s00520-018-4135-z. Epub 2018 Mar 10. Support Care Cancer. 2018. PMID: 29525841
-
Coping with cancer-related cognitive dysfunction: a scoping review of the literature.Disabil Rehabil. 2016;38(4):400-8. doi: 10.3109/09638288.2015.1038364. Epub 2015 Apr 17. Disabil Rehabil. 2016. PMID: 25885669
-
A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.Cancer. 2016 Jun 1;122(11):1782-91. doi: 10.1002/cncr.29891. Epub 2016 May 2. Cancer. 2016. PMID: 27135464 Clinical Trial.
-
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.JNCI Cancer Spectr. 2024 Feb 29;8(2):pkae019. doi: 10.1093/jncics/pkae019. JNCI Cancer Spectr. 2024. PMID: 38556480 Free PMC article.
-
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice.Oncol Res Treat. 2024;47(5):218-223. doi: 10.1159/000538277. Epub 2024 Mar 12. Oncol Res Treat. 2024. PMID: 38471462 Review.
Cited by
-
Addressing cancer survivors' information needs and satisfaction: a systematic review of potential intervention components for survivors with a rare cancer type.Orphanet J Rare Dis. 2024 Oct 18;19(1):387. doi: 10.1186/s13023-024-03403-7. Orphanet J Rare Dis. 2024. PMID: 39425097 Free PMC article.
-
Death-associated protein kinase 1 is associated with cognitive dysfunction in major depressive disorder.Neural Regen Res. 2023 Aug;18(8):1795-1801. doi: 10.4103/1673-5374.361532. Neural Regen Res. 2023. PMID: 36751808 Free PMC article.
References
-
- World Health Organization. Cancer burden rise to 18.1 million new cases and 9.6 million cancer deaths in 2018, Last updated 2018 09 12
-
- Side effects of chemotherapy. Canadian Cancer Society. https://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/chem... . Accessed 25 May 2020
-
- Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, Dew MA, Nutt S, Arvey SR, Rechis R (2016) Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 10(2):302–311. https://doi.org/10.1007/s11764-015-0476-5 - DOI - PubMed
-
- Edelstein K, Bernstein LJ (2014) Cognitive dysfunction after chemotherapy for breast cancer. J Int Neuropsychol Soc 20(4):351–356. https://doi.org/10.1017/S1355617714000149
-
- Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22(11):2233–2239. https://doi.org/10.1200/JCO.2004.08.094 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous